Oral vs Injectable: Navigating Patient Choice in Weight Management

Explore the latest breakthroughs, guidance and treatment strategies in polypoidal choroidal vasculopathy (PCV). Credit available for this activity expires: 11/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/polypoidal-choroidal-vasculopathy-how-second-generation-2026a100155b?ecd=bdc_podcast_libsyn_mscpedu

Discover oral incretins as alternatives in obesity care. Credit available for this activity expires: 11/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/oral-vs-injectable-navigating-patient-choice-weight-2026a10014pl?ecd=bdc_podcast_libsyn_mscpedu

How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice? Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/european-alzheimers-care-live-case-based-forum-amyloid-2026a1001215?ecd=bdc_podcast_libsyn_mscpedu

Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM. Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/deciphering-clinical-data-transthyretin-cardiac-amyloidosis-2026a100110n?ecd=bdc_podcast_libsyn_mscpedu

A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening? Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010phecd=bdc_podcast_libsyn_mscpedu

Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression. Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga-nephropathy-management-evolving-treatment-2026a10010le?ecd=bdc_podcast_libsyn_mscpedu

ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-therapy-early-breast-cancer-2026a10010lp?ecd=bdc_podcast_libsyn_mscpedu

Do you know who to test, when to test, and which biomarker test to use? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_podcast_libsyn_mscpedu

Do you know how to meet the challenges of treating uveitic macular edema? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podcast_libsyn_mscpedu

Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management. Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-outcomes-patient-2026a1000xq5?ecd=bdc_podcast_libsyn_mscpedu